This biotech company specializes in the production and purification of customized lentiviral vectors for cell and gene therapy. They offer cost-effective and rapid solutions for both R&D purposes and clinical trials, aiming to improve the accessibility and affordability of gene therapies.
Funding
Funding not disclosed
Founders
Product
Problem
The development of cell and gene therapies is often hindered by the high cost and slow turnaround times associated with the production of customized lentiviral vectors. This can limit accessibility for both research and clinical applications.
Solution
BioViros specializes in the production and purification of customized lentiviral vectors, offering a cost-effective and rapid solution to accelerate cell and gene therapy development. By streamlining the manufacturing process and maintaining world-class quality, BioViros aims to improve the accessibility of these therapies for patients worldwide. They leverage expertise in cell biology, virus production, and biologics purification to innovate and improve lentivirus vector manufacturing.
Target Audience
BioViros serves researchers and companies involved in cell and gene therapy development, including those focused on CAR-T therapy, seeking a reliable and cost-effective source of custom lentiviral vectors.
Features
- Custom lentiviral vector design and production tailored to specific cell and gene therapy applications
- Streamlined purification process for high-titer, research-grade and clinical-grade vectors
- GMP-compliant manufacturing to ensure product quality and consistency
- Rapid turnaround times to accelerate research and clinical development timelines